CanadaBis Capital / Stigma Grow Announce Corporate Update and Launching of 7 New SKU’s in Alberta

0
41

Red Deer, Alberta–(Newsfile Corp. – December 1, 2021) – CanadaBis Capital Inc. (TSXV: CANB) (“CanadaBis” or “the Company”) with its subsidiary Stigma Grow, is a Canadian cannabis concentrates company focused on capitalizing growth and diversification opportunities. The Company is proud to report certain operational updates.

Our goal remains steadfast: to be a profitable cash flowing company. Steady growth remains the key to our success, with our focus being on low cost, high quality products. Holding all services in house, we expect to continue to see profitable margins from all of our offerings. As the concentrates market continues to grow we will continue to introduce new products to the markets.

Over the next two months alone, we are launching 7 unique SKU’s including

  1. Grape Ape Resin infused Pre rolls with 41.8% THC the highest number seen(1) to date in the pre roll category.
  2. OG Lime killer Moon rocks (a combination of dried flower, live resin and kief) with up to 50% THC. A true legacy market product that is making its debut November 19th at the AGLC.
  3. High Priestess – an exciting new brand of “female focused” items. All of which were formulated with our retailers and budtenders feedback on products they hoped would enter the market.
    1. First High Priestess product is a new line of Organic Live Rosin Vape Carts
    2. Second is a revolutionary “Live CBD” vape carts providing multiple other cannabanoids and terp profiles that CBD distillate does not.
    3. Third, being a blend of live resin and live CBD vape cart, to bring balance.
  4. Holiday Line of Vape carts bringing joy to the season.
    1. Spiced apple Resin Vape cart
    2. Peppermint twist Resin Vape cart

“We are very excited to see the hard work of the team transfer to added sales and long term customers,” says CEO Travis McIntyre.

Stigma Grow existing product line DAB BODS and NGL continues to do excellent and holding the number 1 spot in many categories of concentrates.(1)

The Company is thrilled to announce that is has signed Contracts with three more in house sales reps to provide more coverage to British Columbia, Alberta, Saskatchewan and Ontario, with Manitoba coming soon. The in house reps will have direct access to company data and provide direct feedback which will position Stigma Grow to compete with black market pricing and potency, “Our goal remains to attract consumers who, to-date, have been unmoved by the pricing and product selection of the legal market. The Company believes this approach will lead to long-term stable margins within an underserved niche – providing a great platform to build real, long-term revenues with impressive bottom-line performance,” says Travis McIntyre, CEO

CanadaBis has also closed the first tranche of its previously announced non-brokered private placement consisting of 1,153,846 Units (“Unit”) at a price of $0.13 per Unit to raise gross proceeds of $150,000. Each unit consisted of one common share and one common share warrant. Each common share purchase warrant (a “Warrant”) entitles the holder to purchase one additional share at a price of $0.25 per share for a period of three years following closing or until December 1, 2024.

The Units were offered to an accredited investor and all securities issued under the offering are subject to a hold period of four months plus one day or April 2, 2022. No finder fees were paid in connection with the financing.

About Stigma Grow

Stigma Grow is a cutting-edge cannabis cultivation and extraction company positioned advantageously to meet the unmet market demands and stigmas within the legal cannabis industry head on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada’s legal cannabis industry.

About CanadaBis Capital Inc.

CanadaBis Capital Inc. (TSXV: CANB) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the fast-emerging global cannabis market. By targeting organic growth opportunities alongside the right-fit partners, we remain focused on finding and capitalizing on chances to grow, diversify and continue to lead our industry.

For more information on CanadaBis Capital, 1998643 (Stigma Grow), or INDICAtive Collection please visit www.canadabis.com, www.stigmagrow.ca, www.indicativecollection.ca or contact:

Investor Relations
Info@CanadaBis.com
1-888-STIGMA1

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to our business and operations; timing of the Company’s profitability; the demand and sales volumes of the

Company’s products, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company’s products to compete with the pricing and product availability on the black-market; the market demand for the Company’s products; and assumptions concerning the Company’s competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company’s continuous disclosure on SEDAR at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements.

Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.


1 According to headset data October 2021

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/106213

LEAVE A REPLY

Please enter your comment!
Please enter your name here